# Daniel H. Palmer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-h-palmer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,616 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 63 |
| i10-index | 163 |
| Last Known Institution | University of Liverpool |
| OpenAlex ID | https://openalex.org/A5025272654 |
| ORCID iD | https://orcid.org/0000-0002-5766-9990 |
| Works | 407 |

## Researcher papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial](https://scholariq.org/papers/second-line-folfox-chemotherapy-versus-active-symptom-control-for-advanced/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [University of Liverpool](https://scholariq.org/institutions/university-of-liverpool/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.